Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesEffects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro
BJU International, 07/16/09
Juengel E et al. - Both AEE788 and VPA profoundly block the interaction of RCC cells with endothelium and extracellular matrix and reduce tumour growth in vitro. Therefore, this combined regimen warrants further preclinical and possible clinical study for treating advanced RCC.
Related Articles
Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells
British Journal of Haematology, 10/08/09
Relevance Score: 78%
Cancer incidence and mortality after treatment with folic acid and Vitamin B12
JAMA, 11/18/09
Relevance Score: 68%
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Relevance Score: 67%
Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid
Clinical Infectious Diseases, 11/16/09
Relevance Score: 66%
Globus sensation and increased upper esophageal sphincter pressure with distal esophageal acid perfusion
European Archives of Oto-Rhino-Laryngology, 11/06/09
Relevance Score: 66%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues
Journal of Cancer Research & Clinical Oncology, 12/03/09
Connective Tissue Growth Factor-(CTGF, CCN2) - A Marker, Mediator and Therapeutic Target for Renal Fibrosis
Nephron: Experimental Nephrology, 12/03/09
Smad3-dependent and -independent pathways are involved in peritoneal membrane injury
Kidney International, 12/03/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues
Journal of Cancer Research & Clinical Oncology, 12/03/09
Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma
Histopathology, 12/03/09
Total fluid and specific beverage intake and risk of renal cell carcinoma in Canada
Cancer Epidemiology, 12/03/09
Article Search
Sponsor